[ADJUVANTED INFLUENZA VACCINES: DATA FROM DIRECT COMPARATIVE STUDIES]

Area of Science:

• Immunology
• Vaccinology
• Pharmaceutical Sciences

Context:

• Influenza vaccines are crucial for disease control but face limitations.
• Adjuvanted vaccines offer a promising strategy to enhance vaccine efficacy.
• Current adjuvants exhibit suboptimal effectiveness and safety profiles.

Purpose:

• To summarize published direct comparative studies of adjuvants for influenza vaccines.
• To highlight the lack of adequate comparative trials, especially across different adjuvant groups (nature/source, mechanism of action).
• To identify promising avenues for novel adjuvant research and development.

Summary:

• A review of existing comparative studies on influenza vaccine adjuvants reveals significant data gaps.
• There is a critical need for well-designed trials comparing major adjuvant categories.
• Promising adjuvant approaches include chitosan-based formulations, oil-in-water emulsions, and multi-component systems.

Impact:

• Informing the selection of optimal existing adjuvants.
• Guiding the development of novel, safe, and effective adjuvants for future influenza vaccines.
• Advancing the field of vaccine adjuvant research for improved public health outcomes.